BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18726787)

  • 1. Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk.
    Bonsignore MR; Zito A
    Arch Physiol Biochem; 2008 Oct; 114(4):255-60. PubMed ID: 18726787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive sleep apnea syndrome and cardiovascular diseases.
    Fava C; Montagnana M; Favaloro EJ; Guidi GC; Lippi G
    Semin Thromb Hemost; 2011 Apr; 37(3):280-97. PubMed ID: 21455862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular morbidity associated with obstructive sleep apnea syndrome].
    Destors M; Tamisier R; Baguet JP; Levy P; Pepin JL
    Rev Mal Respir; 2014 Apr; 31(4):375-85. PubMed ID: 24750957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular consequences of obstructive sleep apnea syndrome].
    Lorenzi Filho G; Genta PR; Pedrosa RP; Drager LF; Martinez D
    J Bras Pneumol; 2010 Jun; 36 Suppl 2():38-42. PubMed ID: 20944980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The obstructive sleep apnoea syndrome in obesity: a conspirator in the shadow].
    Salvador J; Iriarte J; Silva C; Gómez Ambrosi J; Díez Caballero A; Frühbeck G
    Rev Med Univ Navarra; 2004; 48(2):55-62. PubMed ID: 15382614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity Indices for Obstructive Sleep Apnea Syndrome Reflecting Glycemic Control or Insulin Resistance.
    Isobe Y; Nakatsumi Y; Sugiyama Y; Hamaoka T; Murai H; Takamura M; Kaneko S; Takata S; Takamura T
    Intern Med; 2019 Nov; 58(22):3227-3234. PubMed ID: 31327833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue is influenced by hypoxia of obstructive sleep apnea syndrome independent of obesity.
    Thorn CE; Knight B; Pastel E; McCulloch LJ; Patel B; Shore AC; Kos K
    Diabetes Metab; 2017 Jun; 43(3):240-247. PubMed ID: 28131740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does physical exercise reduce excessive daytime sleepiness by improving inflammatory profiles in obstructive sleep apnea patients?
    Alves Eda S; Ackel-D'Elia C; Luz GP; Cunha TC; Carneiro G; Tufik S; Bittencourt LR; de Mello MT
    Sleep Breath; 2013 May; 17(2):505-10. PubMed ID: 22760814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood obesity and obstructive sleep apnea syndrome.
    Arens R; Muzumdar H
    J Appl Physiol (1985); 2010 Feb; 108(2):436-44. PubMed ID: 19875714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and obstructive sleep apnoea syndrome: current perspectives.
    Baguet JP; Barone-Rochette G; Pépin JL
    J Hum Hypertens; 2009 Jul; 23(7):431-43. PubMed ID: 19129854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive sleep apnea syndrome: An important piece in the puzzle of cardiovascular risk factors.
    Costa C; Santos B; Severino D; Cabanelas N; Peres M; Monteiro I; Leal M
    Clin Investig Arterioscler; 2015; 27(5):256-63. PubMed ID: 25496654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of cardiovascular damage in obstructive sleep apnea].
    Torre-Bouscoulet L; Castorena-Maldonado A; Sada-Ovalle I; Meza-Vargas MS
    Rev Invest Clin; 2008; 60(6):502-16. PubMed ID: 19378837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea syndrome is a systemic disease. Current evidence.
    Zamarron C; García Paz V; Riveiro A
    Eur J Intern Med; 2008 Oct; 19(6):390-8. PubMed ID: 18848171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea.
    Pataka A; Riha RL
    Curr Cardiol Rep; 2013 Aug; 15(8):385. PubMed ID: 23873341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between obstructive sleep apnea syndrome and obesity: A new perspective on the pathogenesis in terms of organ crosstalk.
    Kuvat N; Tanriverdi H; Armutcu F
    Clin Respir J; 2020 Jul; 14(7):595-604. PubMed ID: 32112481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to avoid cardiovascular consequences of the obstructive sleep apnea syndrome?].
    Szajerska-Kurasiewicz A; Lasyk D; Łoboda D; Simionescu K; Gibiński M; Pol-Romik J; Gołba KS
    Wiad Lek; 2018; 71(6):1254-1261. PubMed ID: 30267510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
    Ryan S; Taylor CT; McNicholas WT
    Thorax; 2009 Jul; 64(7):631-6. PubMed ID: 19561283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome.
    Makino S; Fujiwara M; Suzukawa K; Handa H; Fujie T; Ohtaka Y; Komatsu Y; Aoki Y; Maruyama H; Terada Y; Hashimoto K; Sugimoto T
    Horm Metab Res; 2009 Mar; 41(3):221-6. PubMed ID: 19003725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome.
    Duchna HW; Orth M; Schultze-Werninghaus G; Guilleminault C; Stoohs RA
    Sleep Breath; 2005 Sep; 9(3):97-103. PubMed ID: 16021522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.